Previous efforts to control cellular behaviour have largely relied upon various forms of genetic engineering. Once the genetic content of a living cell is modified, the behaviour of that cell typically changes as well. However, other methods of cellular control are possible. All cells sense and respond to their environment. Therefore, artificial, non-living cellular mimics could be engineered to activate or repress already existing natural sensory pathways of living cells through chemical communication. Here we describe the construction of such a system. The artificial cells expand the senses of Escherichia coli by translating a chemical message that E. coli cannot sense on its own to a molecule that activates a natural cellular response. This methodology could open new opportunities in engineering cellular behaviour without exploiting genetically modified organisms.
S ynthetic biology thus far has relied upon the engineering of new cellular function through the insertion and deletion of genetic information in living cells. This genetic engineering based approach has progressed rapidly. There is now available a set of well-characterized biological parts 1-3 that can be used to build complex genetic circuitry within and between the living cells [4] [5] [6] . Further, entire genomes can be edited 7 and synthesized 8 , suggesting that fully designed organisms with heretofore unseen capabilities are likely in the future.
Despite the wide range of technologies and target pathways exploited, the desire to control microorganisms to date has always employed direct genetic intervention. The limitations of these prevalent methods are due to the difficulties of engineering living systems, including evolutionary pressures that may alter engineered pathways over time and the potential long-term consequences of altering ecosystems with engineered organisms. However, it may not be necessary to genetically modify living cells. Extant life is already extremely complex, endowed with numerous sensory and metabolic pathways tuned by billions of years of evolution to be efficiently responsive to changing intracellular and extracellular conditions. A simple change in pH, for example, results in the up and downregulation of nearly 1,000 genes in Escherichia coli 9 . In other words, cells are already capable of sensing many different stimuli and capable of performing many tasks. Therefore, it should be possible to exploit these existing cellular pathways to control cellular behaviour without changing the genetic makeup of the cells.
Here we explore this idea of engineering E. coli through alternative means by targeting the sensory pathways of E. coli. To do so without altering the genetic content of the bacterium, we instead construct artificial cells that could interact with natural cells in order to evoke a behavioural response. The artificial cells in this system function as chemical translators that sense molecules that E. coli alone cannot sense. In response, the artificial cells release a molecule that E. coli can naturally respond to, thereby translating an unrecognized chemical message into a recognized chemical message. In this way, the sensory capabilities of E. coli are expanded without altering the genetic content of the bacterium. The artificial cell is built with a phospholipid vesicle containing isopropyl b-D-1-thiogalactopyranoside (IPTG), DNA, and transcription-translation machinery. The DNA template codes for a previously selected riboswitch that activates translation in response to the presence of theophylline 10 . The theophylline riboswitch controls the synthesis of the pore forming protein a-hemolysin (aHL). Therefore, in the presence, but not the absence, of theophylline a pore forms that releases entrapped IPTG. E. coli alone does not respond to theophylline, and IPTG does not cross the vesicle membrane of the artificial cell in the absence of the pore. The ability of E. coli to receive the chemical message sent by the artificial cells is assessed in two ways. First, the fluorescence of E. coli carrying a plasmid encoding a fluorescent protein behind an IPTG-responsive, lac operator sequence is evaluated. Second, the gene expression of untransformed E. coli is monitored by reverse transcription quantitative PCR (RT-qPCR). To our knowledge, this is the first artificial, cell-like system capable of translating unrecognized signals into a chemical language that natural cells can recognize. The integration of artificial translator cells with natural cells represents a new strategy to introduce synthetic features to a biological system while circumventing the need for direct genetic manipulation.
Results
The theophylline-sensing device is functional in vitro. To build artificial cells that sense theophylline and in response release IPTG ( Fig. 1) , a theophylline-sensing genetic device was built with a T7 transcriptional promoter, a theophylline riboswitch and a gene encoding a fusion between aHL and super folder GFP at the carboxy terminus. If functioning properly, this arrangement should result in the expression of protein and thus green fluorescence only in the presence of theophylline. However, cell-free expression in the presence and absence of theophylline showed similar levels of fluorescence ( Fig. 2a ). Since this same riboswitch was previously shown to function in vitro 11 , the sequence of the aHL-GFP gene was more closely examined. Multiple pairs of potential ribosome binding sites (RBS) and start codons were identified within the aHL portion of the gene that were in-frame with the GFP-encoding region. The theophylline riboswitch controls translation, meaning that sequences behind the theophylline riboswitch are always transcribed. Translation from the RBS within the riboswitch is activated by direct binding of theophylline to the messenger RNA. Therefore, if additional sequences outside of the riboswitch but within the aHL portion of the gene were recognized by the ribosome, then regardless of the theophylline concentration, the expression of truncated peptide products with fluorescently active GFP would have been possible. To test if such internal RBSs were present, the theophylline riboswitch and thus the RBS preceding the aHL-GFP sequence was deleted. In vitro transcription-translation of this construct showed the accumulation of fluorescence over time similar to the riboswitch containing construct ( Fig. 2b ). Sequence analysis revealed three potential RBS-start codon pairs within the aHL coding portion of the gene. Of these, a putative RBS of AAAGAA was selected as the most likely candidate for giving fluorescent protein expression based on sequence composition and spacing 12 . The putative internal RBS was removed by mutation to TCTACC, resulting in a carboxy-terminal GFP tagged K30S E31T aHL construct. Fluorescence from this mutated construct was reduced threefold, consistent with the removal of an internal RBS ( Fig. 2b ). Finally, K30S E31T aHL-GFP was placed behind the theophylline riboswitch to test the activity of the cell-free sensing device. A clear difference was observed between protein expression in the presence and absence of theophylline ( Fig. 2c ), and the fluorescence arising in the absence of theophylline was within 20% of the construct lacking an RBS upstream of the full gene. The data were consistent with a functioning riboswitch sensor with background fluorescent protein expression arising from internal RBS within aHL. Therefore, the final artificial cellular mimic described below was built with aHL lacking a GFP-tag to avoid complications arising from the expression of truncated fluorescent protein product.
Active aHL is produced in response to theophylline in vitro. To ensure that the cell-free expressed aHL was active as a pore, the ability of aHL to degrade rabbit red blood cells was assessed through a standard haemolysis assay 13 . Each construct was expressed in vitro at 37°C for 6 h after which, an aliquot was removed and added to red blood cells. Haemolysis was quantified by measuring attenuance at 650 nm. In the presence of theophylline, 90% haemolysis was observed when the genetic construct containing a riboswitch-controlled aHL was expressed. The cell-free expression of the same construct in the absence of theophylline gave haemolysis levels similar to the negative control reactions ( Fig. 2d ), as was expected for a functioning theophylline riboswitch that controls the production of aHL. Control reactions with commercial aHL-purified protein and in vitro-expressed aHL and aHL-GFP all were fully active ( Fig. 2d , Supplementary  Table 2 ), whereas aliquots from in vitro-expressed GFP alone and aHL with a carboxy-terminal His-tag were inactive (Supplementary Table 2 ). aHL with a carboxy-terminal His-tag was previously shown to have reduced activity 14 . Also, comparison of the riboswitch activity fluorescence data with the haemolysis assay data was consistent with the production of GFP containing protein fragments from an internal RBS without an active aHL domain. For example, the aHL-GFP construct lacking one of the putative internal RBSs failed to produce protein with haemolysis activity (Supplementary Table 2 ), despite giving rise to fluorescence during in vitro transcription-translation ( Fig. 2b) .
Artificial cells can translate chemical messages for E. coli. After demonstrating that the riboswitch was able to control the in vitro expression of aHL in response to theophylline and that the expressed aHL molecules formed functional pores, the component parts were next assembled inside of phospholipid vesicles to build artificial cells. Theophylline is capable of passing through the membrane of vesicles 11 . Phospholipid vesicles were generated in the presence of IPTG, transcription-translation machinery and DNA encoding aHL under the control of the theophylline riboswitch. The vesicles were then purified by dialysis at 4°C to remove unencapsulated molecules. The receiver bacterial cells were mid-exponential phase E. coli BL21(DE3) pLysS carrying a The removal of the theophylline riboswitch and thus, the RBS preceding the start codon of aHL-GFP shows production of a fluorescent protein product when incubated with transcriptiontranslation machinery ( À RBS). The removal of a putative internal RBS within the aHL coding portion of the fusion construct significantly decreases the production of the fluorescent protein product ( À RBS mutant). (c) The activity of the theophylline-sensing device is observable by fluorescence when an internal RBS is removed. The top and middle curves are the in vitro expression of aHL-GFP behind the theophylline riboswitch in the presence ( þ theo) and absence of theophylline ( À theo), respectively. Background fluorescent protein production is shown with the same construct lacking the theophylline riboswitch ( À RBS mutant) used in b. (d) The cell-free expression of theophylline riboswitch-controlled aHL-degraded red blood cells (RBCs) in the presence ( þ theo) but not the absence of theophylline ( À theo). Control reactions include the expression of an aHL construct lacking the theophylline riboswitch (aHL) and RBCs alone (negative control). RBC degradation was monitored by attenuance at 22°C. The exploited constructs were SP011A for panel A, SP002A and AS014A for panel B, RL069A and AS014A for c, and RL067A and JF001A for d (Supplementary Table 1 ). Data are averages of three independent reactions. plasmid encoding GFP behind a T7 promoter and a lac operator sequence. In this commonly exploited system, IPTG induces the expression of a chromosomal copy of T7 RNA polymerase in E. coli BL21(DE3) and derepresses the expression of GFP from the plasmid. Background expression is typically low with such an arrangement because of the presence of constitutively expressed lysozyme from pLysS, a natural inhibitor of T7 RNA polymerase.
To test if the artificial cells could function as chemical translators for E. coli, the artificial cells were incubated with E. coli BL21(DE3) pLysS carrying the GFP-encoding plasmid at 37°C, and the fluorescence of E. coli was evaluated by flow cytometry. A control reaction in which theophylline was directly added to E. coli in the absence of artificial cells failed to show green fluorescence after 3 h (Fig. 3a) . Similarly, IPTG loaded vesicles that did not contain the machinery necessary to form pores did not induce fluorescence in E. coli. Therefore, theophylline was not able to induce a detectable response in E. coli, and IPTG could not cross the vesicle membrane in the absence of aHL, which was consistent with permeability measurements ( Supplementary Fig. 1 ). However, when E. coli was incubated with artificial cells and theophylline, 17 ± 10% and 69 ± 3% of the bacteria fluoresced green after 0.5 and 3 h, respectively. When the same experiment was repeated in the absence of theophylline, 3±1% and 24±5% of the bacteria were fluorescent after 0.5 and 3 h, respectively (Fig. 3a,b ). Longer incubations resulted in diminishing differences between the two samples suggesting the presence of low levels of aHL expression in the absence of theophylline. Also, the GFP response was encoded within a medium copy number plasmid. Therefore, higher background levels of GFP were to be expected in comparison with gene expression from the chromosome. The flow cytometry experiments were consistent with the ability of artificial cells to translate an unrecognized chemical signal (theophylline) into a signal (IPTG) that E. coli could respond to.
Although the artificial cells were capable of communicating with E. coli, the induction of GFP synthesis, as observed above, exploited an engineered response. To assess whether artificial cells could elicit a natural, chromosomally encoded response, RT-qPCR was used to measure gene expression from the lac operon of E. coli. The lac operon is one of the most thoroughly characterized sensory pathways 15 . The presence of allolactose (or the non-hydrolyzable analogue IPTG) induces the expression of lacZ, lacY and lacA. To facilitate detection of E. coli responding to the chemical message sent from the artificial cells, E. coli BL21 (DE3) pLysS were grown in LB supplemented with glucose to decrease the background expression of the lac operon and then transferred to M9 minimal media prior to incubation with artificial cells. The artificial cells were prepared as described for the GFP induction experiments above. After incubating together artificial cells with E. coli in the presence and absence of theophylline for 4 h, aliquots were collected for RNA isolation. The RNA was then reverse transcribed and lacZ, lacY, and lacA expression quantified by qPCR. The RNA isolated from bacteria incubated with artificial cells plus theophylline showed on average over 20-fold higher lacZYA expression than samples incubated with artificial cells alone (calculated from AC/(AC þ theo) as shown in Fig. 3c ). Taken together, the data are consistent with the ability of artificial cells to translate chemical messages and induce both engineered and natural pathways in E. coli.
Discussion
Direct genetic engineering of living cells is not needed to control cellular behaviour. It is possible, instead, to coerce desired activity through communication with artificial cells. The foundation for such technologies has already been laid by both cell-free and in vivo studies. Engineered communication paths between living cells have been constructed to coordinate cellular activities in response to external stimuli 6, 16 and are being developed for therapeutic purposes 17 . In these systems, sender cells often can process information and in response release molecules that affect other cells. What has been shown herein builds on these past efforts but does so by integrating reconstituted, non-living systems with living cells. This allows for the genetic engineering component of the system to be moved from the living, evolving, replicating cells to the more controllable, ephemeral artificial cells. When the artificial cells degrade, the natural cells go back to their original state, thereby diminishing the possibility of unintended long-term consequences. For example, rather than engineering bacteria to search for and clean up environmental contaminants, artificial cells could be built to sense the contaminant molecules and in response release chemoattractants that bring natural bacteria capable of feeding on the contaminants 18 to the affected site. Several recent reports have described the engineering of seekand-destroy bacteria for the eradication of tumours or bacterial infections [19] [20] [21] [22] . However, these methods ultimately rely on administering living bacteria to the patient. Artificial cells could be built to carry out similar tasks if the sensor module of the artificial cell was designed to detect the chemical conditions associated with the ailment. For instance, rather than spraying engineered bacteria into the lungs of cystic fibrosis patients, artificial cells could be built to detect the presence of Pseudomonas aeruginosa biofilms through the quorum signalling molecules that are naturally secreted by the organism, such as N-(3-oxododecanoyl)-L-homoserine lactone, a molecule capable of crossing membranes without the aid of transporters. Subsequently, the artificial cells could release small molecules, for example, D-amino acids 23 , to disperse the biofilm and thus clear the infection. Moreover, the use of dispersion rather than killing would decrease the probability of the bacteria developing resistance. Similar strategies with artificial cells could be developed to substitute for engineered probiotics that integrate with gut microbiota 24 and prevent disease 25, 26 .
There are several limitations to these first generation artificial cells. First, heterogeneity in membrane lamellarity and in encapsulation efficiency 27 results in a mixture of artificial cells with varying degrees of activity. Microfluidic-based methods for compartment formation and solute encapsulation would likely alleviate many of the complications associated with vesicle-tovesicle and batch-to-batch variability. Also, a system fully dependent upon the permeability properties of the membrane limits the types of molecules that can be sensed and released. The development of specific membrane-associated sensors and transporters will likely be necessary as the complexity of artificial cells increase. Finally, the simple release of encapsulated molecules means that release could result from compartment degradation as opposed to an engineered response to the detection of a specific molecule. It is, therefore, important to develop an output that is mediated by synthesis so that compartment degradation would only result in the release of inactive starting molecules. An example of such a system is the biological nanofactory described by Fernandes et al. 28 that synthesizes a signalling molecule from S-(5 0 -deoxyadenosin-5 0 )-L-homocysteine via two enzymatic steps.
The absence of a living chassis opens up greater opportunities to assemble or biofabricate various mechanisms or functions that would be difficult to implement with living cells. For example, chemical systems housed within inorganic and peptide-based compartments are capable of sensing the environment through, in part, the gating behaviour of the non-lipid compartment 29, 30 . Further, artificial cells can synthesize and release signalling molecules sensed by living cells without exploiting genetically encoded parts 31, 32 . The possibility of merging advances with nongenetically encoded and genetically encoded parts may lead to the construction of artificial cells that are better able to imitate natural cellular life 33, 34 .
Methods
Genetic constructs. The gene encoding Staphylococcus aureus aHL was synthesized by Genscript. Super folder GFP (BBa_I746916) was from the registry of standard biological parts (http://parts.igem.org). The theophylline riboswitch sequence was from Lynch and Gallivan 10 and was amplified from a previously described construct 11 . All genes were subcloned into pET21b (Novagen) with NdeI and XhoI restriction sites. Mutagenesis was performed by Phusion site-directed mutagenesis (Thermo Scientific). All constructs were confirmed by sequencing at Genechron or Eurofins MWG Operon. Sequences of all the exploited constructs are listed in Supplementary Table 1 . All experiments were repeated at least three times. Data are reported as averages with standard error, or representative runs are shown.
In vitro characterization of the riboswitch. Plasmids were amplified in E. coli Novablue (Novagen) and purified with Wizard Plus SV Minipreps DNA Purification System (Promega). Plasmid DNA was phenol-chloroform extracted, ethanol precipitated and resuspended in deionized and diethyl pyrocarbonatetreated water. PCR products were purified with Wizard Plus SV Gel and PCR Clean-Up Systems (Promega). Transcription-translation reactions used the PURExpress In Vitro Protein Synthesis Kit (New England Biolabs) supplemented with 20 units of Human Placenta RNase Inhibitor (New England Biolabs). Reactions were monitored by fluorescence with a CFX96 Touch real-time PCR (Bio-Rad) using the SYBR green filter set.
a-hemolysin activity. Each construct was expressed with the PURExpress In Vitro Protein Synthesis Kit at 37°C in a final volume of 25 ml either in the presence or absence of 1.5 mM theophylline for 6 h. Rabbit red blood cell (RBC) suspensions (adjusted to D ¼ 0.1 at 650 nm) were added to a microplate where the reaction mixtures were serially diluted. Changes in attenuance of the RBC suspension were measured at 650 nm with a microplate reader (UVmax, Molecular Devices) for 30 min at 22°C as reported in Laventie et al. 35 The results are reported as percentage of haemolysis or as the time necessary to reach 50% of haemolysis.
Preparation of E. coli receiver cells. Mid-exponential E. coli BL21(DE3) pLysS transformed with a plasmid encoding super folder GFP behind a T7 promoter and a lac operator sequence (CD101A 12 ) were grown in LB supplemented with 100 mg ml À 1 ampicillin and 34 mg ml À 1 chloramphenicol to an optical density of 0.5 at 600 nm. A quantity of 200 ml aliquots in 10% (vol/vol) glycerol were flash frozen with liquid nitrogen and stored at À 80°C for later use. Aliquots were rapidly thawed and mixed with 2 ml LB supplemented with 100 mg ml À 1 ampicillin and 34 mg ml À 1 chloramphenicol and incubated for 2 h at 37°C with 220 r.p.m. shaking. Finally, the cells were gently pelleted and resuspended in 1 ml M9 minimal media.
Preparation of artificial cells. Vesicles were prepared as previously described 36, 37 . Briefly, 12.5 mg 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 12.5 mg cholesterol (Avanti Polar Lipids) in chloroform were mixed in a round bottom flask. A thin lipid film was made through rotary evaporation with a Buchi Rotovapor R-210 equipped with a Buchi Vacuum Pump V-700 for 5 h. A quantity of 2 ml DEPC-treated deionized water was then added to the thin lipid film and vigorously vortexed. The resulting liposome dispersion was homogenized with an IKA T10 basic homogenizer at a power setting of 4 for 1 min. A quantity of 100 ml aliquots were frozen in liquid nitrogen or dry ice and lyophilized overnight in a vacuum concentrator (Centritrap DNA concentrator, Labconco) at 40°C. The lyophilized empty liposomes were stored at À 20°C. A quantity of 100 ml aliquots of freeze-dried liposomes were hydrated with 25 ml of 100 mM IPTG (Sigma) dissolved in 50 mM HEPES pH7.6, 25 ml of the PURE system, 500 ng DNA and 20 units of human placenta RNase inhibitor (final volume of 50 ml), unless otherwise noted. Solutions were gently mixed for 30 s.
To remove extravesicular material, the vesicles were dialyzed following a method previously described by Zhu and Szostak 38 . The original membranes of 500 ml Slide-a-Lyzer dialysis cassettes (Pierce) were exchanged with 25 mm diameter polycarbonate track-etched membranes with a 1 mm pore size (Whatman). A quantity of 50 ml of unpurified vesicles were loaded onto the center of the dialysis system with a 100 ml Hamilton syringe and dialyzed against 250 ml of buffer A (50 mM HEPES, 10 mM MgCl 2 , 100 mM KCl, pH 7.6) with stirring. The first four rounds of dialysis were for 10 min each. Two more rounds of dialysis in which the buffer was changed after 30 min incubations were further performed. All dialysis steps were carried out at 4°C.
Artificial-natural cell communication. Purified vesicles containing DNA, the PURE system, and IPTG were incubated with E. coli BL21(DE3) pLysS transformed with CD101A in M9 minimal media supplemented with 1 mg ml À 1 of Proteinase K and 5 mM theophylline at 37°C in a final volume of 40 ml. Control reactions did not contain theophylline. At different time points, 1 ml was removed and diluted 1:100 in PBS. The sample was then analysed by flow cytometry with a FACSCanto A (BD Biosciences). The FITC filter was used for the detection of positive cells. The incident light was at 488 nm for forward scatter (FSC), side scatter (SSC) and fluorescence. Detection for SSC and fluorescence was at 488±10 nm and 530±30 nm, respectively. The threshold parameters were 200 for both FSC and SSC. The PMT voltage settings were 525 (FSC), 403 (SSC) and 600 (FITC). The flow rate was set to 'low'. For each sample 30,000 events were collected. Reactions were repeated three times on three separate days. Data were analysed using FlowJo software (TreeStar, USA).
Samples were also evaluated by RT-qPCR. Here, the dialyzed vesicles and E. coli were incubated as described above for 4 h at 37°C. Subsequently, the total RNA was extracted with the RNeasy Mini kit (Qiagen). A quantity of 10 ml of 500 ng of RNA was reverse transcribed using RevertAid Reverse Transcriptase (Thermo Scientific). cDNA was quantified with a CFX96 Touch real-time PCR (Bio-Rad) with SYBR green detection. Each sample was diluted to 5 ng and measured in triplicate in a 96 wells plate (Bio-Rad) in a reaction mixture containing SsoAdvanced SYBR green supermix (Bio-Rad) and 180 nM of each primer in a 10 ml finale volume. The primers used to quantify lacZ, lacY and lacA expression were lacZ FW: 5 0 -TACGATGCGCCCATCTACAC-3 0 , lacZ REV: 5 0 -AACAACCC GTCGGATTCTCC-3 0 , lacY FW: 5 0 -GGTTTCCAGGGCGCTTATCT-3 0 , lacY REV: 5 0 -TTCATTCACCTGACGACGCA-3 0 , lacA FW: 5 0 -GCGTCACCATC GGGGATAAT-3 0 , lacA REV: 5 0 -CCACGACGTTTGGTGGAATG-3 0 . Gene expression was normalized to the expression of idnT 39 with the following primers: 5 0 -CTGCCGTTGCGCTGTTTATT-3 0 and 5 0 -GATTTGCTCGATGGTGCGTC-3 0 .
